Outcome heterogeneity of TP53-mutated myeloid neoplasms and the role of allogeneic hematopoietic cell transplantation

被引：8

作者：

Pasca, Sergiu ^{[1
]}

Haldar, Saurav D. ^{[1
]}

Ambinder, Alexander ^{[1
]}

Webster, Jonathan A. ^{[1
]}

Jain, Tania ^{[1
]}

Dalton, W. Brian ^{[1
]}

Prince, Gabrielle T. ^{[1
]}

Ghiaur, Gabriel ^{[1
]}

Dezern, Amy E. ^{[1
]}

Gojo, Ivana ^{[1
]}

Smith, B. Douglas ^{[1
]}

Karantanos, Theodoros ^{[1
]}

Schulz, Cory ^{[1
]}

Stokvis, Kristin ^{[1
]}

Levis, Mark J. ^{[1
]}

Jones, Richard J. ^{[1
]}

Gondek, Lukasz P. ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Div Hematol Malignancies, Baltimore, MD 21218 USA

来源：

HAEMATOLOGICA | 2024年 / 109卷 / 03期

关键词：

LEUKEMIA; MUTATIONS; IMPACT;

D O I：

10.3324/haematol.2023.283886

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：948 / 952

页数：5

共 15 条

[1] Implications ofTP53allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes [J].

Bernard, Elsa ;

Nannya, Yasuhito ;

Hasserjian, Robert P. ;

Devlin, Sean M. ;

Tuechler, Heinz ;

Medina-Martinez, Juan S. ;

Yoshizato, Tetsuichi ;

Shiozawa, Yusuke ;

Saiki, Ryunosuke ;

Malcovati, Luca ;

Levine, Max F. ;

Arango, Juan E. ;

Zhou, Yangyu ;

Sole, Francesc ;

Cargo, Catherine A. ;

Haase, Detlef ;

Creignou, Maria ;

Germing, Ulrich ;

Zhang, Yanming ;

Gundem, Gunes ;

Sarian, Araxe ;

van de Loosdrecht, Arjan A. ;

Jadersten, Martin ;

Tobiasson, Magnus ;

Kosmider, Olivier ;

Follo, Matilde Y. ;

Thol, Felicitas ;

Pinheiro, Ronald F. ;

Santini, Valeria ;

Kotsianidis, Ioannis ;

Boultwood, Jacqueline ;

Santos, Fabio P. S. ;

Schanz, Julie ;

Kasahara, Senji ;

Ishikawa, Takayuki ;

Tsurumi, Hisashi ;

Takaori-Kondo, Akifumi ;

Kiguchi, Toru ;

Polprasert, Chantana ;

Bennett, John M. ;

Klimek, Virginia M. ;

Savona, Michael R. ;

Belickova, Monika ;

Ganster, Christina ;

Palomo, Laura ;

Sanz, Guillermo ;

Ades, Lionel ;

Della Porta, Matteo Giovanni ;

Smith, Alexandra G. ;

Werner, Yesenia .

NATURE MEDICINE, 2020, 26 (10) :1549-+

[2] Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care [J].

Doehner, Hartmut ;

Dolnik, Anna ;

Tang, Lin ;

Seymour, John F. ;

Minden, Mark D. ;

Stone, Richard M. ;

Bernal del Castillo, Teresa ;

Al-Ali, Haifa Kathrin ;

Santini, Valeria ;

Vyas, Paresh ;

Beach, C. L. ;

MacBeth, Kyle J. ;

Skikne, Barry S. ;

Songer, Steve ;

Tu, Nora ;

Bullinger, Lars ;

Dombret, Herve .

LEUKEMIA, 2018, 32 (12) :2546-2557

[3] Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation [J].

Gondek, L. P. ;

Zheng, G. ;

Ghiaur, G. ;

DeZern, A. E. ;

Matsui, W. ;

Yegnasubramanian, S. ;

Lin, M-T ;

Levis, M. ;

Eshleman, J. R. ;

Varadhan, R. ;

Tucker, N. ;

Jones, R. ;

Gocke, C. D. .

LEUKEMIA, 2016, 30 (09) :1916-1920

[4] Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease [J].

Hourigan, Christopher S. ;

Dillon, Laura W. ;

Gui, Gege ;

Logan, Brent R. ;

Fei, Mingwei ;

Ghannam, Jack ;

Li, Yuesheng ;

Licon, Abel ;

Alyea, Edwin P. ;

Bashey, Asad ;

Deeg, H. Joachim ;

Devine, Steven M. ;

Fernandez, Hugo F. ;

Giralt, Sergio ;

Hamadani, Mehdi ;

Howard, Alan ;

Maziarz, Richard T. ;

Porter, David L. ;

Scott, Bart L. ;

Warlick, Erica D. ;

Pasquini, Marcelo C. ;

Horwitz, Mitchell E. .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (12) :1273-+

[5] Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibrosis [J].

Jain, Tania ;

Tsai, Hua-Ling ;

DeZern, Amy E. ;

Gondek, Lukasz P. ;

Elmariah, Hany ;

Bolanos-Meade, Javier ;

Luznik, Leonido ;

Fuchs, Ephraim ;

Ambinder, Richard ;

Gladstone, Douglas E. ;

Imus, Philip ;

Webster, Jonathan ;

Prince, Gabrielle ;

Ghiaur, Gabriel ;

Smith, B. Douglas ;

Ali, Syed Abbas ;

Ambinder, Alexander ;

Dalton, William B. ;

Gocke, Christian B. ;

Huff, Carol Ann ;

Gojo, Ivana ;

Swinnen, Lode ;

Wagner-Johnston, Nina ;

Borrello, Ivan ;

Varadhan, Ravi ;

Levis, Mark ;

Jones, Richard J. .

TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (05) :259.e1-259.e11

[6] TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p [J].

Jasek, M. ;

Gondek, L. P. ;

Bejanyan, N. ;

Tiu, R. ;

Huh, J. ;

Theil, K. S. ;

O'Keefe, C. ;

McDevitt, M. A. ;

Maciejewski, J. P. .

LEUKEMIA, 2010, 24 (01) :216-219

[7] Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation [J].

Lindsley, R. C. ;

Saber, W. ;

Mar, B. G. ;

Redd, R. ;

Wang, T. ;

Haagenson, M. D. ;

Grauman, P. V. ;

Hu, Z. -H. ;

Spellman, S. R. ;

Lee, S. J. ;

Verneris, M. R. ;

Hsu, K. ;

Fleischhauer, K. ;

Cutler, C. ;

Antin, J. H. ;

Neuberg, D. ;

Ebert, B. L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (06) :536-547

[8] Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML [J].

Murdock, H. Moses ;

Kim, Haesook T. ;

Denlinger, Nathan ;

Vachhani, Pankit ;

Hambley, Bryan ;

Manning, Bryan S. ;

Gier, Shannon ;

Cho, Christina ;

Tsai, Harrison K. ;

McCurdy, Shannon ;

Ho, Vincent T. ;

Koreth, John ;

Soiffer, Robert J. ;

Ritz, Jerome ;

Carroll, Martin P. ;

Vasu, Sumithira ;

Perales, Miguel-Angel ;

Wang, Eunice S. ;

Gondek, Lukasz P. ;

Devine, Steven ;

Alyea, Edwin P., III ;

Lindsley, R. Coleman ;

Gibson, Christopher J. .

BLOOD, 2022, 139 (24) :3546-3557

[9] Genomic Classification and Prognosis in Acute Myeloid Leukemia [J].

Papaemmanuil, Elli ;

Gerstung, Moritz ;

Bullinger, Lars ;

Gaidzik, Verena I. ;

Paschka, Peter ;

Roberts, Nicola D. ;

Potter, Nicola E. ;

Heuser, Michael ;

Thol, Felicitas ;

Bolli, Niccolo ;

Gundem, Gunes ;

Van Loo, Peter ;

Martincorena, Inigo ;

Ganly, Peter ;

Mudie, Laura ;

McLaren, Stuart ;

O'Meara, Sarah ;

Raine, Keiran ;

Jones, David R. ;

Teague, Jon W. ;

Butler, Adam P. ;

Greaves, Mel F. ;

Ganser, Arnold ;

Doehner, Konstanze ;

Schlenk, Richard F. ;

Doehner, Hartmut ;

Campbell, Peter J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (23) :2209-2221

[10] Outcomes in Patients with Poor-Risk Cytogenetics with or without TP53 Mutations Treated with Venetoclax and Azacitidine [J].

Pollyea, Daniel A. ;

Pratz, Keith W. ;

Wei, Andrew H. ;

Pullarkat, Vinod ;

Jonas, Brian A. ;

Recher, Christian ;

Babu, Sunil ;

Schuh, Andre C. ;

Dail, Monique ;

Sun, Yan ;

Potluri, Jalaja ;

Chyla, Brenda ;

DiNardo, Courtney D. .

CLINICAL CANCER RESEARCH, 2022, 28 (24) :5272-5279

← 1 2 →